ABSTRACT. It has been suggested that pertussis toxin may be caused by the Ptx contained within vaccine preparations (Ptx) is involved in the pathogenesis of the adverse neu- (9, 10) . Ptx. also referred to as IAP, LPF, or HSF is one of the rologic reactions that can occur in infants and children exotoxins produced by B~r d e t~l l u pertzissis. It is a n oligomeric after pertussis immunization. One group of investigators protein (Mr = 1 17,000) consisting of an A (active) protomer and has recently reported that a clinical syndrome with patho-a B (binding) oligomer (I I) and is known to have a wide variety logical features very similar to post-pertussis vaccination of biological activities (12) . The diversity of these activities in encephalopathy can be induced in specific strains of mice vivo is related to the multiplicity of target cells that are susceptible after their immunization with bovine serum albumin (BSA) to the toxin's effects (1 3-15). Many of these effects have been and Ptx. The aim of this investigation was to further ascribed to the capacity of Ptx to modify intracellular cyclic characterize the immunologic mechanisms operative in this nucleotide metabolisn~ (14. 16) . The A-protomer of Ptx is capamurine model. Studies were undertaken to determine ble of altering the regulation of CAMP by ADP-ribosylating whether the role played by Ptx in this condition required nucleotide-binding proteins. Ni, a protein capable of inhibiting the A-protomer of the toxin to enter a cell and ADP-the activity of adenylate cyclase (17) , transducin, a protein caribosylate a nucleotide binding protein (a Class I activity) pable of enhancing the activity of cyclic G M P phosphodiesterase or was dependent upon the binding of the B-oligomer of (18) , and No, a protein whose function and relationship to Ni is the toxin to the surface of target cells (a Class I1 activity). currently unknown (19, 20) , have all been reported to be riboThe results of our experiments have established that the sylated by enzymatic activity of Ptx. Recent evidence also sugdisease induced by coimmunizing mice with Ptx and BSA gests that Ptx may be capable of modulating transduction systems is due to an immediate type hypersensitivity reaction rather other than adenylate cyclase (2 1-23). In addition, it is now than an encephalopathy and that the mechanism of action appreciated that a number of the biological activities of this of Ptx in this system seems to be dependent upon a Class toxin, especially those involved in immunomodulation, are un-I1 activity of the toxin and independent of its ADP-ribosyl related to its ADP-ribosyl transferase activity (21 ,I\ \lIO\\ll 11) 1 iihlc 1 . t l l~ 131-ciricuhatiori 01' intact macropliagcs \\it11 i.itlic~-I't\ oi mI't\ rcsultcd in a n i.tlir~\:ilc.nt rcdui.tron ol'tlic. a\:iil:iblC c~ntloycno~rs mcmt>r.anc ~>r-oti~i~is \usccptil>lc to r r i l~c~\ ! lalion \ \ i l l 1 ac,li\ alctl I't\ \uI?sccl~~cnt to rni'mi>l'ane I>r'i'1>:ir-:11rori.
I:\l>criri-ients ncr-c also i.onti~rc.tccl \\Iic.r-c~ pr-ep;lr:itioris 01' mat,-rol~liage mernhranes ncrC inclrI>:itcti \ \~t l i '[I I]h:Il) in tlic pr-c\-cnce of citlicr I't\ or. rnf't\. I-tic r.adiolal>clc%tl ~ilc.rnl>raric Ilic'ri \\ere \\ashed arid siilyecteti to sotiium cioticc\I ~~~IIl~tc-l>ol~acr-!Iamid? gel c1cct1-opliorcsis. Oril! one tland 01' ~.arlioac~ti\ 11) \\as li)urid. cor-rcsporiii~ig to a molecular. \\ciglit 01' 4 I k 0 a Sc,rntillatron counting ol' the isolateti 1 I kI>a Iland clctcrrnincd that tlic al~ilit) of mPtx and Ptx to catal!/c the ~II)I'-r-rhos> Intiori 01' the membrane pr-otcin \\.as cclui\alcrit (tiara not slio\vn). I Iicsc rcsults intiicatc that hotli Ptx arid ml'tx \\ el-c capahlc ol' cndogcT- RSA o r mPtx a n d I3SA prior to scrum collection a n d a d o l~t i v e t r a n s k r to susceptible recipients. '1.0 cvaluatc the role ol'thc toxin in the cff'crcnt phase of the proccss. recipient animals wcl-e "primed" with either Ptx o r mPtx 24 h prior to reccrvinb 1 1111 111 uric serum ancl the RSA challenge. As shown in Table 6 . animals that wcrc i r n m u n i~e d with I' tx anti t3SA were capable of producing a humoral substance that, when adoptively transferred to I'txprctrcatcd recipients. was capable of transkrring the disease process. 1)onor ;tnirnals that \+,cr-c trcatcd with mPtv arid in]-m u n i~c d with RSA did not generate the humoral cornponcnts necessary to adoptively transf'cr the disorder to susccptiblc rccipients (group A). f:ur-thcrn~orc, ml'tx was also incapable of I-endcring normal recipients susccptiblc to the pathological pr-occss caused by the adoptive transfer of serum from R S and I'tx i r n r n u n i~c d donors ( g l -O L I~ I)). 'I'hesc results indicate that the involvcmcnt of I'tx in both the allcrcnt a n d e t k r e n t phascs of this proccss ar-c likely associated with its class 11, and not class I. :ind an IV ir~fi~vori ol'cithcr I'tx or-ml'rx (100 ng) on days 0 and +2. -t 0 1 1 d;iy h all animal\ were cliallcr~gcd nith ;in 11' injection 01' 13SA ( I rng). Al~~m:ils were then otxcr-vet1 closcl) for lethargy. tacli!j~nca. scl/urc activity. kind death.
j: All animals in gr-oup I: (cupc~lrncnt I ) and group R (cxpc~-imcnt 1) dlcd witll~rl 2 11 01' I3SA ~ri.jccr~orl. . F I.yri~phoicl cells and Immune \crurn were prepared from tiorlor arlini:il\ as dcscrlbcti iri "hfater~al ;inti r1i~tl1od\ " l:acl~ ~C'CIPICIII :1111rii:rI I C C C~\ C~ a n 1V ~r~lilsion 01' I x 10' Ihmph node cells or 0.21 ml of Irnmunc scrum. Selected groups of rcclplcnt\ had rccci\cil an IV ~n j c c t~o~i <>I' 1'1\ 24 h prior to :~dopt~vc transkr. An 11' injcct~on of I i S was g i~c n to all rcc~jllents I li after rccci\in$ the inl'~is~on ol'irnmunc \cru!n or \!rnj>lio~ti c.c'll\ 11 Animals wcrc obscrvcd closely lilr lethargy. tachypnca. c)r~nosi\. sci/urc acti\it>. and death. S; All I-ccipicnt animals In group\ l i (cxl3crirncnt I ) and I ) (exper-~mcnt 2) d~etl \b~tli~n 2 h oi'recc~\~ing the 11' injcclion of I3S4.
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WIEDMEIER ET AL. (27) and suggested the possibility of an anaphylactic-type reaction being responsible.The original intention of the present investigation was to determine whether the mechanism of action of Ptx in this murine model was related to the toxin's capacity to induce a class I or class I1 activity. Our studies, however, have now established that Steinman's model is not one of neurologic encephalopathy but rather is the result of vascular collapse secondary to an anaphylactic reaction. Several lines of experimental evidence support this conclusion: 1) sensitivity to the BSA-Rx-induced disease can be passively transferred with the immune serum obtained from sensitized animals into Ptxtreated recipients; 2) animals that are immunized with BSA and R x and then pretreated with serotonin antagonists prior to BSA challenge d o not develop the typical clinical manifestations of the disorder; and 3) symptoms of the condition can possibly be alleviated by giving BSA-Ptx immunized animals fluid therapy as soon as clinical manifestations are noted following the BSA challenge. In mice, both IgG, and IgE can function to induce antigenspecific release of mediators from mast cells and basophils that are capable of initiating immediate type hypersensitivity reactions (36). Antibodies belonging to the IgG, subclass, unlike IgE, are not inactivated by heating at 56" C or by sulfhydryl reagents (37) . We have determined that heating the serum from BSA-Ptx sensitized animals for 30 min at 56" C did not diminish the ability of that immune serum to passively transfer anaphylactic sensitivity to Ptx primed recipients (data not shown). These results suggest, but d o not prove, that antibodies of the IgG, subclass may be involved in the BSA-Ptx-induced immediate hypersensitivity reaction. Further work is in progress to test this hypothesis.
Our studies have also revealed that the development of anaphylaxis in this murine system exhibits some interesting characteristics. By employing preparations of Ptx and mPtx in parallel we were able to demonstrate that the ADP-ribosyl transferase capacity of pertussis toxin is insufficient to initiate the BSA-Ptxinduced immediate type hypersensitivity reaction. Our findings also indicate that the development of this reaction is associated with a class I1 or immunopotentiating activity of the toxin. In a series of adoptive transfer experiments we further demonstrated that both the donor of the humoral component and the recipients of the immune serum need to be treated with Ptx for the BSAPtx induced hypersensitivity response to take place. mPtx could not substitute for Ptx in either the afferent or efferent phase of this process.
While the murine model system described Steinman et al. (26) originally looked quite promising, our finding that the experimentally produced condition actually represents an immediatetype hypersensitivity reaction rather than a true encephalopathy indicates that an experimental model for human postpertussis vaccination encephalopathy is still lacking.
